Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
COSCIENS Biopharma Inc. (T.CSC) had Free Cash Flow per Share of -0.95 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
14.76M |
|
-- |
|
-- |
|
-- |
|
-1.00M |
|
-- |
|
-0.25M |
|
-0.25M |
|
-0.25M |
|
-0.25M |
|
14.76M |
|
-0.25M |
|
-1.00M |
|
-0.53M |
|
3.14M |
|
3.14M |
|
4.69 |
|
3.98 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
25.85M |
|
-- |
|
-- |
|
-- |
|
4.83M |
|
21.02M |
|
21.02M |
|
21.02M |
|
3.18M |
|
| Cash Flow Statement Financials | |
-2.99M |
|
-0.03M |
|
-0.11M |
|
10.03M |
|
6.87M |
|
-3.16M |
|
0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.57 |
|
-- |
|
-- |
|
0.11 |
|
0.13 |
|
42.00% |
|
-38.67% |
|
-38.67% |
|
-- |
|
-9.69% |
|
569.76% |
|
-2.98M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
1.00 |
|
0.95 |
|
95.05 |
|
-1.19% |
|
-1.19% |
|
-0.97% |
|
-1.07% |
|
6.60 |
|
|
Free Cash Flow per Share |
-0.95 |
-0.95 |
|